Foresite Capital Management IV, LLC Diversified Active

CIK: 0001704132 · Show all filings

Period: Q3 2025 (← Previous) (Next →)

Filing Date: Nov 14, 2025

Total Value ($000): $182,608 (100.0% shares, 0.0% debt)

Holdings (6)

PHVS Pharvaris N.V. 65.3%

Value ($000) $119,226 Shares 4,778,581 Est. Cost $26.89 Unrealized -17.5%

CYTK CYTOKINETICS INC 13.8%

Value ($000) $25,188 Shares 458,295 Est. Cost $41.20 Unrealized 0.0%

MAZE Maze Therapeutics, Inc. 7.4%

Value ($000) $13,552 Shares 522,657 Est. Cost $12.04 Unrealized +40.2%

LYEL Lyell Immunopharma, Inc. 7.1%

Value ($000) $12,998 Shares 800,399 Est. Cost $9.11 Unrealized +25.3%

XENE Xenon Pharmaceuticals Inc. 3.5%

Value ($000) $6,424 Shares 160,000 Est. Cost $32.62 Unrealized +8.0%

RLAY Relay Therapeutics, Inc. 2.9%

Value ($000) $5,220 Shares 1,000,000 Est. Cost $7.47 Unrealized -49.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
PHVS	Pharvaris N.V.	4,778,581	$119,226	65.3%	$26.89	-17.5%	COM	N69605108
CYTK	CYTOKINETICS INC	458,295	$25,188	13.8%	$41.20	0.0%	COM	23282W605
MAZE	Maze Therapeutics, Inc.	522,657	$13,552	7.4%	$12.04	+40.2%	COM	578784100
LYEL	Lyell Immunopharma, Inc.	800,399	$12,998	7.1%	$9.11	+25.3%	COM	55083R203
XENE	Xenon Pharmaceuticals Inc.	160,000	$6,424	3.5%	$32.62	+8.0%	COM	98420N105
RLAY	Relay Therapeutics, Inc.	1,000,000	$5,220	2.9%	$7.47	-49.0%	COM	75943R102